Suppr超能文献

长链非编码RNA在肝细胞癌中扮演关键角色。

Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma.

作者信息

Mehra Mrigaya, Chauhan Ranjit

机构信息

Studio of Computational Biology & Bioinformatics, Biotechnology Division, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, India.

Academy of Scientific & Innovative Research, Chennai, India.

出版信息

Biomark Cancer. 2017 Nov 2;9:1179299X17737301. doi: 10.1177/1179299X17737301. eCollection 2017.

Abstract

Hepatocellular carcinoma (HCC) is a major malignancy in the liver and has emerged as one of the main cancers in the world with a high mortality rate. However, the molecular mechanisms of HCC are still poorly understood. Long noncoding RNAs (lncRNAs) have recently come to the forefront as functional non-protein-coding RNAs that are involved in a variety of cellular processes ranging from maintaining the structural integrity of chromosomes to gene expression regulation in a spatiotemporal manner. Many recent studies have reported the involvement of lncRNAs in HCC which has led to a better understanding of the underlying molecular mechanisms operating in HCC. Long noncoding RNAs have been shown to regulate development and progression of HCC, and thus, lncRNAs have both diagnostic and therapeutic potentials. In this review, we present an overview of the lncRNAs involved in different stages of HCC and their potential in clinical applications which have been studied so far.

摘要

肝细胞癌(HCC)是肝脏的一种主要恶性肿瘤,已成为全球主要癌症之一,死亡率很高。然而,HCC的分子机制仍知之甚少。长链非编码RNA(lncRNAs)最近作为功能性非蛋白质编码RNA崭露头角,它们参与了从维持染色体结构完整性到时空基因表达调控等多种细胞过程。最近许多研究报道了lncRNAs与HCC的关系,这有助于更好地理解HCC中潜在的分子机制。长链非编码RNA已被证明可调节HCC的发生发展,因此,lncRNAs具有诊断和治疗潜力。在本综述中,我们概述了参与HCC不同阶段的lncRNAs及其目前已研究的临床应用潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e849/5673005/2721f1b9b1da/10.1177_1179299X17737301-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验